Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Treasury Shares (2022 - 2025)

Historic Treasury Shares for Rxo (RXO) over the last 4 years, with Q4 2025 value amounting to $1.7 million.

  • Rxo's Treasury Shares fell 241.52% to $1.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 million, marking a year-over-year decrease of 241.52%. This contributed to the annual value of $1.7 million for FY2025, which is 241.52% down from last year.
  • Rxo's Treasury Shares amounted to $1.7 million in Q4 2025, which was down 241.52% from $1.7 million recorded in Q4 2024.
  • Over the past 5 years, Rxo's Treasury Shares peaked at $1.7 million during Q4 2024, and registered a low of $100000.0 during Q4 2023.
  • In the last 4 years, Rxo's Treasury Shares had a median value of $1.3 million in 2022 and averaged $1.1 million.
  • In the last 5 years, Rxo's Treasury Shares tumbled by 9005.14% in 2023 and then surged by 161237.9% in 2024.
  • Quarter analysis of 4 years shows Rxo's Treasury Shares stood at $1.0 million in 2022, then plummeted by 90.05% to $100000.0 in 2023, then skyrocketed by 1612.38% to $1.7 million in 2024, then fell by 2.42% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q4 2025, $1.7 million for Q4 2024, and $100000.0 during Q4 2023.